STOCK TITAN

Forian Inc. to Announce 2022 Second Quarter Results on August 11, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Forian Inc. (Nasdaq:FORA) will release its financial results for the quarter ending June 30, 2022, on August 11, 2022, after market close. A conference call to discuss the earnings will occur at 4:30 p.m. ET on the same day, with a live webcast available. Forian specializes in software, data, and analytics services for healthcare and cannabis industries, offering SaaS solutions and data management capabilities to enhance operational performance. The company emphasizes caution regarding forward-looking statements due to inherent risks and uncertainties.

Positive
  • Forian continues to provide SaaS solutions and data analytics, targeting growth in healthcare and cannabis sectors.
Negative
  • Forward-looking statements highlight risks related to COVID-19 impact and uncertainty in achieving strategic goals.

NEWTOWN, PA, July 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended June 30, 2022 on Thursday, August 11, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 11, 2022 to discuss the results.

To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/kgeukv8d. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly following its conclusion will be available at the same site.

About Forian

Forian provides a unique suite of SaaS solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators. For more information, please visit the Company's website at www.forian.com.

Cautionary Statements Regarding Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the control of Forian, and are not guarantees of future results, such as statements about the anticipated benefits of the business combination transaction involving Forian, Medical Outcomes Research Analytics, LLC and Helix Technologies, Inc., future financial and operating results, company strategy and intended product offerings and market positioning. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the impact of the COVID-19 pandemic on Forian's business, operations, strategy and goals; Forian's ability to execute on its strategy; the timing of the introduction of new product offerings; and the additional risks and uncertainties set forth more fully under the caption "Risk Factors" in Forian's Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 31, 2022, and elsewhere in Forian's filings and reports with the SEC. Forward-looking statements contained in this announcement are made as of the date hereof, and Forian undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

Media and Investor Contact:
267-225-6263
forian.com/investors
ir@forian.com

SOURCE Forian Inc.



FAQ

When will Forian announce its Q2 2022 financial results?

Forian will announce its Q2 2022 financial results on August 11, 2022, after market close.

What time is the Forian conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on August 11, 2022.

What services does Forian provide?

Forian provides software, data management, and analytics services for the healthcare and cannabis industries.

What should investors be cautious about regarding Forian's forward-looking statements?

Investors should be cautious due to risks related to COVID-19 and uncertainties in the company's strategic goals.

Forian Inc.

NASDAQ:FORA

FORA Rankings

FORA Latest News

FORA Stock Data

61.41M
14.40M
52.12%
13.69%
0.47%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States of America
NEWTOWN